
The study evaluated the safety and efficacy of transcatheter arterial chemoembolization (TACE) for the treatment of refractory gross hematuria (RGH) and urinary retention (UR) secondary to localized advanced prostate cancer (PCa). In conclusion, TACE using EPI-eluting HS plus IA infusion of docetaxel is a safe and effective treatment option for advanced PCa patients with GRH and UR. It could be considered an effective treatment alternative if there was no other therapeutic choice.
Like
Save
Share